Related Experiment Video
Updated: Mar 29, 2026

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
WNT signaling in glioblastoma and therapeutic opportunities
Yeri Lee1, Jin-Ku Lee2, Sun Hee Ahn1
1Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Abstract:
WNTs and their downstream effectors regulate proliferation, death, and migration and cell fate decision. Deregulation of WNT signaling is associated with various cancers including GBM, which is the most malignant primary brain cancer. In this review, we will summarize the experimental evidence supporting oncogenic roles of WNT signaling in GBM and discuss current progress in the targeting of WNT signaling as an anti-cancer approach. In particular, we will focus on (1) genetic and epigenetic alterations that lead to aberrant WNT pathway activation in GBM, (2) WNT-mediated control of GBM stem cell maintenance and invasion, and (3) cross-talk between WNT and other signaling pathways in GBM. We will then review the discovery of agents that can inhibit WNT signaling in preclinical models and the current status of human clinical trials.
Insights
This review explores the WNT signaling pathway
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- WNT signaling regulates fundamental cellular processes like proliferation and cell fate.
- Aberrant WNT signaling is implicated in various cancers, notably Glioblastoma (GBM).
- GBM is the most aggressive form of primary brain cancer.
Purpose of the Study:
- To review the oncogenic role of WNT signaling in GBM.
- To discuss WNT pathway targeting as an anti-cancer strategy for GBM.
- To summarize current research on WNT signaling in GBM.
Main Methods:
- Review of experimental evidence on WNT signaling in GBM.
- Focus on genetic and epigenetic alterations in GBM.
- Analysis of WNT-mediated control of GBM stem cells and invasion.
Main Results:
- WNT pathway activation is linked to GBM development and progression.
- WNT signaling influences GBM stem cell maintenance and invasiveness.
- Cross-talk between WNT and other signaling pathways is critical in GBM.
Conclusions:
- WNT signaling is a key driver of GBM.
- Targeting WNT signaling shows promise for GBM treatment.
- Further research and clinical trials are needed for WNT-targeted therapies.
More Related Videos
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...

